CORRECT (Jun 3): AstraZeneca Cancer Drugs Have Positive Trial Results
(Correcting that AstraZeneca presented two-year progression free survival data from its Polo trial not three-year overall survival data and that 10% of patients on placebo in the Lynparza trial no Read More